Author
Listed:
- S. Parijatham Kanchana
- Poojita Pabbu
- Y. Sabitha
Abstract
Diabetes is a chronic, metabolic disorder characterized by Hyperglycaemia (elevated levels of blood glucose), which leads over time to serious damage to the heart, blood vessels, eyes etc. India is referred to as the “diabetes capital of the world†because. Around 77 million people are diagnosed with diabetes which makes it the second most affected country after China. Since antidiabetic drugs prescribed today have frequent side effects, research on plant-based alternatives is needed. This study aims to find out the antidiabetic activity of Indigofera tirunelvelica and Basella alba by evaluating their in vitro inhibitory enzyme activities. Treatment may involve inhibition of enzymes responsible for carbohydrate degradation, such as Alpha glucosidase and alpha amylase, in order to maintain blood sugar levels. For this experiment, the plant extract was made using methanol, chloroform, and distilled water. The activity of amylase and glucosidase was measured spectrophotometrically. Inhibitory potential was measured using regression equation. IC₅₀ values were calculated for all the samples including Acarbose. The IC₅₀ value of Acarbose(standard) was 13.91μg/ml. The IC₅₀ value of Indigofera tirunelvelica (36.83μg/ml) was less compared to Basella alba (53.96μg/ml) This indicates a stronger inhibitory effect of Indigofera tirunelvelica as it has the nearest value to that of the standard (Acarbose). Significant inhibition was seen in Indigofera tirunelvelica compared to Basella alba which suggests that, these plants can contribute for future research in the treatment of diabetes.
Suggested Citation
S. Parijatham Kanchana & Poojita Pabbu & Y. Sabitha, 2025.
"In Bitro Studies on Alpha Glucosidase and Alpha Amylase Inhibitory Activities of Indigofera Tirunelvelica and Basella Alba,"
Convergence of Technology & Biology ─ Transforming Life Sciences, in: Malathi Varma & S.Parijatham Kanchana & G.Sony (ed.),Convergence of Technology & Biology ─ Transforming Life Sciences, chapter 17, pages 180-190,
Shanlax Publications.
Handle:
RePEc:dax:ctbtls:978-93-6163-763-6:p:180-190
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:dax:ctbtls:978-93-6163-763-6:p:180-190. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: S.Lakshmanan (email available below). General contact details of provider: .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.